Urology · Easton, MD
NPI
1710094792
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
490 Cadmus Ln Ste 104
Easton, MD, 21601
Phone (410) 820-0560
Groups this clinician bills Medicare through
Medicare paid, 2024
$283K
4,563 services
Medicare patients, 2024
1,131
Average age 76
Drug cost, 2024
$1.0M
5,464 prescriptions
Company payments, 2025
$278
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard D Cespedes was code 81003 (clinical chemistry), 1,094 times for 835 patients. In total Richard D Cespedes billed 4,563 services in 55 codes, and Medicare paid $283K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 1,094 | 835 | $2.19 | $2,395 |
| 99214 Office E&M - Established | Office | 931 | 697 | $89.00 | $83K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 446 | 386 | $12.82 | $5,719 |
| 99204 Office E&M - New | Office | 283 | 283 | $115.39 | $33K |
| 51798 Ultrasound - Nonspecific | Office | 115 | 109 | $8.46 | $973 |
| 64566 Musculoskeletal | Office | 113 | 36 | $84.96 | $9,601 |
| 57267 Other Organ Systems | Facility | 84 | 42 | $195.68 | $16K |
| 51784 Neurologic | Office | 84 | 83 | $25.26 | $2,122 |
| 51797 Other Organ Systems | Office | 83 | 82 | $147.02 | $12K |
| 52000 Cystourethroscopy | Facility | 74 | 73 | $58.76 | $4,349 |
| 51728 Other Organ Systems | Office | 71 | 70 | $276.49 | $20K |
| 52000 Cystourethroscopy | Office | 56 | 55 | $170.31 | $9,537 |
| 51715 Other Organ Systems | Facility | 52 | 24 | $152.12 | $7,910 |
| 57265 Other Organ Systems | Facility | 43 | 43 | $671.73 | $29K |
| 57283 Other Organ Systems | Facility | 42 | 42 | $277.89 | $12K |
By year: 2022 $311K for 3,965 services; 2023 $318K for 4,921 services; 2024 $283K for 4,563 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,094 | 835 | $2.19 | $2,395 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard D Cespedes prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 1,186 prescriptions and refills. In total Richard D Cespedes wrote 5,464 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 1,186 | 1,651 | 233 | $722K |
| Tolterodine Tartrate Er Tolterodine Tartrate | 594 | 1,026 | 121 | $52K |
| Triamcinolone Acetonide Generic | 553 | 575 | 284 | $5,062 |
| Solifenacin Succinate Generic | 523 | 874 | 135 | $22K |
| Trospium Chloride Generic | 406 | 599 | 98 | $20K |
| Cephalexin Generic | 369 | 377 | 227 | $1,344 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 358 | 591 | 77 | $11K |
| Estradiol Generic | 193 | 603 | 127 | $13K |
| Gemtesa Vibegron | 163 | 191 | 29 | $89K |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 131 | 197 | 24 | $8,855 |
| Ciprofloxacin Hcl Generic | 105 | 105 | 71 | $356 |
| Oxybutynin Chloride Generic | 101 | 130 | 22 | $1,267 |
| Mirabegron Er Mirabegron | 90 | 158 | 37 | $49K |
| Hydroxyzine Hcl Generic | 77 | 109 | 17 | $724 |
| Methenamine Hippurate Generic | 73 | 83 | 19 | $3,312 |
Brand drugs: - claims; generic drugs: 4,031 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard D Cespedes $278 ($278 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $54.65.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.